AI Summary & Key Takeaways
AI InsightHuman immunoglobulin replacement therapy is the mainstay of therapy for the patients with antibody deficiencies such as X-linked agammaglobulinemia (X-LA), common variable immunodeficiencies (CVI), hyper-IgM syndrome and combined B- and T-cell defect.In this review, you will find the answers to commonly asked questions related to IVIG and recent advances in IVIG therapy.
📌 3 Key Takeaways
Abstract
The protective effect of immunoglobulin administration has been known for the last 50 years. Immune globulin (IG)is a sterile IgG product, prepared for intramuscular, subcutaeous injection and intravenous infusion. Intravenous immunoglobulin (IVIG) has several advantages over other immunoglobulins. Immunoglobulin preparations are safe and effective. Human immunoglobulin replacement therapy is the mainstay of therapy for the patients with antibody deficiencies such as X-linked agammaglobulinemia (X-LA), common variable immunodeficiencies (CVI), hyper-IgM syndrome and combined B- and T-cell defect.In this review, you will find the answers to commonly asked questions related to IVIG and recent advances in IVIG therapy.
Özet
İmmünglobulin tedavisinin koruyucu etkisi son 50 yıldan beri bilinmektedir. İmmünglobulin, IgG içeren steril bir ürün olup adale içine, cilt altına ve intravenöz uygulanabilen preparatları bulunur. Intravenöz immünglobulin (IVIG)’in, diğer immünglobulinlere göre bazı üstünlükleri vardır. Immün globulin preparatları güvenli ve etkilidir. İnsan immünglobulin tedavisinin, X-e bağlı agammaglobulinemi (X-LA), değişken immün yetersizlik (CVI), hiper-IgM sendromu ve kombine B- ve T-hücre eksikliği gibi antikor eksikliği olan hastalar için temel tedavi yöntemidir.Bu yazıda konuya ilişkin en sık sorulan sorulara yanıtlar verilecek ve IVIG tedavisindeki güncel bilgiler aktarılacaktır.